Hello!
To view this content, please sign up or log in – it’s free and easy! Stay ahead with curated regulatory insights designed for professionals like you.
Brief
"On November 28, 2024, the French National Agency for the Safety of Medicines and Health Products (ANSM) issued an update regarding 'Illegal therapy in the treatment of cancer: we take health police decisions against three companies promoting dendritic cell therapies not authorized in France'. The agency took measures to suspend the illegal promotion of this therapy by Immucura, Immunyo, and Iaso Health GmbH, citing a lack of marketing authorization from either the European Commission or ANSM."
Highlights content goes here...
Hello!
To view this content, please sign up or log in – it’s free and easy! Stay ahead with curated regulatory insights designed for professionals like you.
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested
